Search
Search Results
-
Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy
Background and AimsWe and others have previously described that hepatitis B surface antibody (anti-HBs) seems to protect against clinically...
-
Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study
IntroductionSurveillance programs after hepatitis B surface antigen (HBsAg) loss are not yet well established, and the role of hepatitis B surface...
-
Evaluation of factors associated the expression of anti-HBs in children in Hunan Province, China
Background and objectivesVaccine is the most essential avenue to prevent hepatitis B virus (HBV) infection in infants and preschool children in...
-
Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study
BackgroundSerological testing for the presence of Hepatitis B Virus (HBV) markers and anti-HBs titers in infants born to HBsAg positive women is...
-
Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017
IntroductionChildhood vaccination against hepatitis B has been recommended in Germany since 1995. WHO defines a primary vaccination series as...
-
High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy
BackgroundHealthy populations have high rates of sustained vaccine-induced seroprotection to hepatitis B virus, but previous studies in...
-
Seroprotection With Three Dose vs Four Dose Schedule for Hepatitis B Vaccination in Children Living With Human Immunodeficiency Virus: Follow-up Data at 36–42 Months From a Randomized Controlled Trial
ObjectiveTo compare the long-term seroprotection (anti-HBs ≥10 IU/L) in children living with HIV (CLHIV) receiving a 3- or 4-dose double-strength (20...
-
Outcomes of Entecavir Prophylaxis in Hepatitis B Immune Patients Receiving Hepatitis B Infected Kidneys: A Single Center Experience
Purpose of ReviewHepatitis B (HBV) vaccinated patients have mixed responses with regard to antibody titers and subsequent level of immunity. This...
-
Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis
BackgroundGlobally, 257 million people have chronic hepatitis. Even though a safe and effective prophylactic vaccine against HBV infection has been...
-
A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections
BackgroundThe long-term protective effect of hepatitis B vaccine (HepB), the incidence of hepatitis B virus (HBV) vaccine breakthrough infections...
-
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey
BackgroundThe risk of hepatitis B virus (HBV) reactivation remains unclear in people with multiple sclerosis (MS) receiving ocrelizumab. We aimed to...
-
Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study
IntroductionProspective data on the risk of hepatitis B reactivation (HBVr) among patients with resolved HBV infection undergoing anti-CD20...
-
Seroprevalence of Hepatitis A, B and C Among a Sample of Refugees in Egypt: An Exploratory Survey
BackgroundEstimating the prevalence of infectious diseases, including viral hepatitis, among refugees is important for evaluating their health needs...
-
Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study
To evaluate of hepatitis serology and reactivation frequency in patients with rheumatic disease receiving biologic agents. Our study included...
-
Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community
BackgroundViral hepatitis is a significant health concern among indigenous population in the Americas. In Brazil, reports find high endemicity of HBV...
-
Low HBV knowledge is associated with low HBV vaccination uptake in general adult population despite incentivization of HBV vaccination
BackgroundHepatitis B virus (HBV) vaccination in Vietnamese adults remains low and unequally distributed. We conducted a study on HBV-naïve adults...
-
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting
BackgroundDespite the availability of an effective vaccine, chronic hepatitis B virus (HBV) infections remain a major cause of liver cirrhosis and...
-
Changing incidence of hepatitis B and persistent infection risk in adults: a population-based follow-up study from 2011 in China
BackgroundThis study aimed to estimate hepatitis B incidence and chronicity risk in rural adults in China under the background of eliminating viral...
-
Heterogeneity and Hierarchy of Immune Response to Primary Immunization in HIV-Infected Children on HAART and the Impact of an Additional Dose of Vaccine
The nature of vaccine response inferiority is not well studied in children living with HIV (CLHIV). The authors investigated Hepatitis B Virus (HBV)...
-
Two-year immune effect differences between the 0–1–2-month and 0–1–6-month HBV vaccination schedule in adults
BackgroundThe short-term 0–1–2-month hepatitis B virus (HBV) vaccination schedule was previously implemented in the adult population; however, its...
